Michael Carter
Article author
Michael started writing news reports for NAM in 2002. As a former staff member, he wrote and edited the first editions of many of NAM’s booklets and factsheets.
Studies exploring the effectiveness of “abstinence only” programmes to prevent HIV are limited by severe methodological weaknesses, investigators from Oxford University assert in the January 11th edition of AIDS.
The investigators found that abstinence studies did not include enough participants to justify the initiation of large-scale public health initiatives; did not specify procedures used for randomisation; did not report clinically meaningful outcomes (such as incident HIV infections); did not use intent-to-treat analyses; did not provide enough details to demonstrate if interventions were delivered as planned; and did not compare the effectiveness of abstinence programmes with health education initiatives that provided wider information on sexual health, including condom use.
Abstinence-only HIV prevention programmes have been the source of fierce debate in recent years. Often acrimonious discussions have focused on the public health, political and moral aspects of these programmes.
Despite these heated debates, investigators at the Centre for Evidence-Based Medicine at Oxford University were concerned that evidence from clinical trials regarding the effectiveness or otherwise of abstinence programmes were being overlooked. They expressed particular concern that a forthcoming Cochrane review of the clinical effectiveness of abstinence-only education in richer countries, which identified policy and practice implications, is in fact, limited by reporting shortcomings from the trials that informed it.
The Oxford scientists found “recurring reporting deficiencies that may limit the extent to which programme trials can make specific recommendations for policy and practice.
Despite the use of randomised controlled trial designs, no abstinence study met the CONSORT reporting standards and missing data was an obstacle to meta-analysis.
Deficiencies in trial design and reporting in five broad areas were highlighted by the Oxford investigators:
The authors conclude, “abstinence-only programme evaluations…must report key data more completely.”
Underhill K et al. Reporting deficiencies in trials of abstinence-only programmes for HIV prevention. AIDS 21: 266 – 267, 2007.